Drug Shortage Report for PROCTOSEDYL

Last updated on 2019-03-05 History
Report ID 5285
Drug Identification Number 02223260
Brand name PROCTOSEDYL SUPPOSITORIES
Common or Proper name PrPROCTOSEDYL® 0.5% Suppositories
Company Name APTALIS PHARMA CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN
Strength(s) 5MG 5MG 10MG 10MG
Dosage form(s) SUPPOSITORY
Route of administration RECTAL
Packaging size 12 and 24 suppositories
ATC code C05AA
ATC description AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2013-03-01
Estimated end date Unknown
Actual end date 2017-04-05
Shortage status Resolved
Updated date 2019-03-05
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-03-05 French Compare
v4 2019-03-05 English Compare
v3 2017-04-04 French Compare
v2 2017-04-04 English Compare
v1 2017-04-04 English Compare

Showing 1 to 5 of 5